{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:21:04Z","timestamp":1790803264684,"version":"4.1.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1038\/s41433-021-01526-w","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T17:04:14Z","timestamp":1625159054000},"page":"3179-3180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reducing the burden of ocular surface disease with serum eye drops"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3131-2395","authenticated-orcid":false,"given":"Parwez","family":"Hossain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"1526_CR1","doi-asserted-by":"publisher","unstructured":"Hossain P, Siffel C, Joseph C, Meunier J, Markowitz JT, Dana R. Patientreported burden of dry eye disease in the UK: a cross-sectional web-based survey. BMJ Open. 2021 Mar 4;11(3):e039209. https:\/\/doi.org\/10.1136\/bmjopen-2020-039209. PMID: 33664064; PMCID: PMC7934779.","DOI":"10.1136\/bmjopen-2020-039209"},{"key":"1526_CR2","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.jtos.2020.05.006","volume":"18","author":"S Erickson","year":"2020","unstructured":"Erickson S, Sullivan AG, Barabino S, Begovic E, Benitez-Del-Castillo JM, Bonini S, et al. TFOS European Ambassador meeting: Unmet needs and future scientific and clinical solutions for ocular surface diseases. Ocul Surf 2020;18:936\u201362. https:\/\/doi.org\/10.1016\/j.jtos.2020.05.006.","journal-title":"Ocul Surf"},{"key":"1526_CR3","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1136\/bjo.2004.044347","volume":"88","author":"G Geerling","year":"2004","unstructured":"Geerling G, MacLennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. 2004;88:1467\u201374.","journal-title":"Br J Ophthalmol"},{"key":"1526_CR4","doi-asserted-by":"publisher","unstructured":"Rauz S, Koay SY, Foot B et al. The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full report. Eye. 2017. https:\/\/doi.org\/10.1038\/eye.2017.209.","DOI":"10.1038\/eye.2017.209"},{"key":"1526_CR5","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/eye.2017.118","volume":"31","author":"J Than","year":"2017","unstructured":"Than J, Balal S, Wawrzynski J, et al. Fingerprick autologous blood: a novel treatment for dry eye syndrome. Eye. 2017;31:1655\u201363. https:\/\/doi.org\/10.1038\/eye.2017.118.","journal-title":"Eye"},{"key":"1526_CR6","unstructured":"Lomas et al. Patient Reported Outcome Measures for a Large Cohort of Serum Eye Drops Recipients in the UK [EYE-20-1220R \u2013 INSERT FULL CITATION WHEN KNOWN]"},{"key":"1526_CR7","first-page":"CD009327","volume":"2","author":"Q Pan","year":"2017","unstructured":"Pan Q, Angelina A, Marrone M, Stark WJ, Akpek EK. Autologous serum eye drops for dry eye. Cochrane Database Syst Rev 2017;2:CD009327.","journal-title":"Cochrane Database Syst Rev"},{"key":"1526_CR8","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1136\/bjo.2003.026211","volume":"88","author":"BA Noble","year":"2004","unstructured":"Noble BA, Loh RSK, MacLennan S, et al. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol. 2004;88:647\u201352.","journal-title":"Br J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01526-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01526-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01526-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T11:08:15Z","timestamp":1637233695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01526-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1526"],"URL":"https:\/\/doi.org\/10.1038\/s41433-021-01526-w","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"assertion":[{"value":"30 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}